Development and sale of the AI voice sub-chart "Sub Karte-Voice"
First written in FY2024. 1 of 4 entries say "Restated". Latest entry: 2026-09-14.
No other company in this theme has enough history to compare yet.
- 2026-09-14AdvancedRevision of earnings forecasts
「Sales expanded steadily.」
The expansion of sales of the product lineup, including AI Voice Supplementary Chart, is cited as a factor behind the upward revision of the earnings forecast. - FY2025ReframedAnnual report
「The three AI series products, “AI and voice-enabled integrated electronic medical record system Revo.11,” “AI and voice-enabled detailed periodontal examination” and “AI and voice-enabled supplementary patient-record system,” have been collectively named AI and voice-enabled Hiクラテス.」
The AI and voice-enabled supplementary patient-record system has been repositioned from a standalone product as part of the AI and voice-enabled Hiクラテス product line together with Revo.11 and the AI and voice-enabled detailed periodontal examination system. - FY2025-H1RestatedAnnual report
「We have promoted sales of our core products, the “AI Voice Electronic Medical Record Integration System AI-Voice,” “AI Voice Periodontal Examination” and “AI Voice Sub-Record,” under the collective designation “The Three Sacred Treasures of Dental DX.”」
The company continues to expand sales of the AI and voice-enabled supplementary patient-record system as a core DX product line alongside AI-Voice and the AI and voice-enabled periodontal examination system, rather than as a standalone product that has already been released. - FY2024First statedAnnual report
「Then, as the third product in the series, we released the AI voice sub-record “Sub Karte-Voice” on 29 August 2024.」
The company has, for the first time, presented as an independent theme its third product, which uses AI and voice input to record patients' procedures, conversations and changes and share them in real time both within the clinic and at home-visit consultation sites.